Equity Analysis

Company Profile

Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets

Company News

BSE Realty

Industry : Stock Exchanges

BSE Code

ISIN Demat

Book Value()

1131

N.A

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

61.85

706349.6

EPS(TTM)

Face Value()

Div & Yield %:

100

0.26

Back

Orchid Pharma consolidated net profit rises 37.58% in the September 2024 quarter

Nov 11,2024

Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as against Rs 19.80 crore during the previous quarter ended September 2023. Sales rose 12.04% to Rs 222.70 crore in the quarter ended September 2024 as against Rs 198.76 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	222.70	198.76	12
OPM %	13.62	11.73	-
PBDT	34.53	27.86	24
PBT	25.90	20.02	29
NP	27.24	19.80	38